$CLSD
Clearside Biomedical, Inc.

2018 Q1 Form 10-K Financial Statement

#000156459018006055 Filed on March 16, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2016 Q4 2016 Q3
Revenue $0.00 $10.00K $10.00K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.070M $2.390M $1.630M
YoY Change 14.98% 95.9% 52.34%
% of Gross Profit
Research & Development $13.38M $6.970M $3.682M
YoY Change 76.27% 83.42% 59.46%
% of Gross Profit
Depreciation & Amortization $47.00K $20.00K $20.00K
YoY Change 56.67% 100.0% 0.0%
% of Gross Profit
Operating Expenses $16.45M $9.362M $5.311M
YoY Change 60.34% 86.64% 57.41%
Operating Profit -$16.45M
YoY Change 60.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$154.0K -$330.0K -$340.0K
YoY Change 31.62% 240.0%
Pretax Income -$16.61M -$9.690M -$5.650M
YoY Change 60.17% 87.43% 62.36%
Income Tax
% Of Pretax Income
Net Earnings -$16.61M -$9.686M -$5.645M
YoY Change 60.1% 87.35% 62.45%
Net Earnings / Revenue -96860.0% -56450.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$619.3K -$245.7K -$274.7K
COMMON SHARES
Basic Shares Outstanding 31.91M 20.57M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.1M $83.63M $56.90M
YoY Change 30.45% 311.98% 1254.76%
Cash & Equivalents $84.83M $34.82M $36.88M
Short-Term Investments $16.20M $48.81M $20.00M
Other Short-Term Assets $2.200M $290.0K $800.0K
YoY Change -26.67% 625.0% 300.0%
Inventory
Prepaid Expenses $396.0K
Receivables
Other Receivables
Total Short-Term Assets $103.2M $84.32M $57.70M
YoY Change 28.2% 311.66% 1211.36%
LONG-TERM ASSETS
Property, Plant & Equipment $800.0K $94.00K $100.0K
YoY Change -20.0% -39.74% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $42.00K $7.000K
YoY Change -20.0% 500.0%
Total Long-Term Assets $1.300M $496.0K $71.00K
YoY Change -13.33% -13.44% -29.0%
TOTAL ASSETS
Total Short-Term Assets $103.2M $84.32M $57.70M
Total Long-Term Assets $1.300M $496.0K $71.00K
Total Assets $104.5M $84.81M $57.77M
YoY Change 27.44% 302.82% 1183.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.700M $2.594M $1.347M
YoY Change 42.55% 76.58% 68.38%
Accrued Expenses $3.700M $2.791M $1.556M
YoY Change 146.67% 40.6% 19.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.200M
YoY Change 300.0%
Total Short-Term Liabilities $13.80M $5.408M $2.900M
YoY Change 91.67% 4.08% -9.38%
LONG-TERM LIABILITIES
Long-Term Debt $4.100M $7.586M $7.489M
YoY Change -40.58% 78.79% 56.02%
Other Long-Term Liabilities $600.0K $200.0K $251.0K
YoY Change -14.29% -23.37% -72.11%
Total Long-Term Liabilities $4.700M $7.586M $7.740M
YoY Change -38.16% 68.43% 35.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.80M $5.408M $2.900M
Total Long-Term Liabilities $4.700M $7.586M $7.740M
Total Liabilities $18.50M $13.15M $10.83M
YoY Change 25.0% 26.48% 23.1%
SHAREHOLDERS EQUITY
Retained Earnings -$65.25M -$55.56M
YoY Change 65.75%
Common Stock $25.00K $21.00K
YoY Change 733.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.92M $71.66M $46.90M
YoY Change
Total Liabilities & Shareholders Equity $104.5M $84.81M $57.80M
YoY Change 27.44% 302.82% 1184.44%

Cashflow Statement

Concept 2018 Q1 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$16.61M -$9.686M -$5.645M
YoY Change 60.1% 87.35% 62.45%
Depreciation, Depletion And Amortization $47.00K $20.00K $20.00K
YoY Change 56.67% 100.0% 0.0%
Cash From Operating Activities -$15.65M -$6.460M -$6.370M
YoY Change 42.56% 68.67% 102.22%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $12.25M -$29.07M -$20.07M
YoY Change -315.67%
Cash From Investing Activities $12.25M -$29.07M -$20.07M
YoY Change -304.42% 96800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $800.0K
YoY Change
Cash From Financing Activities 79.02M 33.48M 8.030M
YoY Change 1440.31% 67.82%
NET CHANGE
Cash From Operating Activities -15.65M -6.460M -6.370M
Cash From Investing Activities 12.25M -29.07M -20.07M
Cash From Financing Activities 79.02M 33.48M 8.030M
Net Change In Cash 75.61M -2.050M -18.41M
YoY Change -738.87% -112.74% 484.44%
FREE CASH FLOW
Cash From Operating Activities -$15.65M -$6.460M -$6.370M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$15.65M -$6.460M -$6.370M
YoY Change 38.66% 69.55% 102.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
199000
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017Q2 dei Entity Public Float
EntityPublicFloat
153311000
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31913113
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9224000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
28416000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13519000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
610000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
360000
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1314000
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5708000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
239000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
66000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10762000
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
3000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5408000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
140000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
160000
CY2017Q4 us-gaap Liabilities
Liabilities
19078000
CY2016Q4 us-gaap Liabilities
Liabilities
13154000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.97
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.54
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21415000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
71659000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40493000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84813000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25354651
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24573033
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25354651
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24573033
CY2017 clsd License And Collaboration Revenue
LicenseAndCollaborationRevenue
345000
CY2016 clsd License And Collaboration Revenue
LicenseAndCollaborationRevenue
520000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-58408000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-567000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-58975000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-25882000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-17639000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.33
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25311614
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13111067
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2338950
CY2016 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
33459000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
48198000
CY2016 clsd Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
308000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58970000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25895000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17639000
CY2017 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
5057000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
66000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3364000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000
CY2015 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
525000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
705000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-36659000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2016 clsd Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
410000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51377000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-19213000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2015 clsd Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
-1000
CY2017 us-gaap Depreciation
Depreciation
182000
CY2016 us-gaap Depreciation
Depreciation
65000
CY2015 us-gaap Depreciation
Depreciation
60000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3364000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1314000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
705000
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
211000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
283000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
104000
CY2017 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
212000
CY2016 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
108000
CY2015 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
60000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
156000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
52000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
31000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
43000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
833000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
487000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
145000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-882000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1763000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4715000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1424000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
632000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-520000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
500000
CY2017 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
97000
CY2016 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-9000
CY2015 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-9000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-51083000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22709000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13902000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
48116000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
54485000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
68543000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
360000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
306000
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20121000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-49140000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28000
CY2017 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
5057000
CY2016 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
33456000
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
51376000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7857000
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5976000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6330000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5362000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
86390000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25944000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-25600000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14541000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12014000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20283000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8269000
CY2017 us-gaap Interest Paid
InterestPaid
653000
CY2016 us-gaap Interest Paid
InterestPaid
250000
CY2015 us-gaap Interest Paid
InterestPaid
100000
CY2017 clsd Noncash Tenant Improvements Paid By Landlord
NoncashTenantImprovementsPaidByLandlord
637000
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
48198000
CY2016 clsd Reclassification Of Deferred Initial Public Offering Costs
ReclassificationOfDeferredInitialPublicOfferingCosts
1597000
CY2015 clsd Issuance Of Warrant To Purchase Preferred Stock
IssuanceOfWarrantToPurchasePreferredStock
164000
CY2016 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
884000
CY2015 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
525000
CY2016 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
507000
CY2015 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
410000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting periods. Significant items subject to such estimates and assumptions include the accounting for useful lives to calculate depreciation and amortization, clinical trial accruals, share-based compensation expense and income tax valuation allowance. Actual results could differ from these estimates.</p></div>
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk Arising From Cash Deposits in Excess of Insured Limits</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company maintains its cash in bank deposits that at times may exceed federally insured limits. The Company has not experienced any loss in such accounts. The Company believes it is not exposed to any significant risks with respect to its cash balances.</p></div>
CY2017 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
653000
CY2017 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
211000
CY2017 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
62000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPayment
1255000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInNextTwelveMonths
3676000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearTwo
3434000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearThree
2145000
CY2017 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2011-05-26
CY2016Q4 clsd Public Offering Closing Date
PublicOfferingClosingDate
2016-12-14
CY2016Q4 clsd Stock Issued During Period Shares Follow On Offering
StockIssuedDuringPeriodSharesFollowOnOffering
4000000
CY2016Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
9.00
CY2016Q4 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
33400000
CY2016Q4 clsd Underwriting Discounts And Commissions
UnderwritingDiscountsAndCommissions
2500000
CY2017Q1 clsd Offering Expense
OfferingExpense
400000
CY2017 clsd Proceeds From Issuance Of Convertible Preferred Stock And Long Term Debt
ProceedsFromIssuanceOfConvertiblePreferredStockAndLongTermDebt
53900000
CY2017Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
37600000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 clsd Cumulative Net Operating Losses
CumulativeNetOperatingLosses
28000000
CY2016Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.4545
CY2017 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On May 11, 2016, the Company effected a 1-for-2.2 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s convertible preferred stock.
CY2017 clsd Short Term Investments Maturity Period Range Start
ShortTermInvestmentsMaturityPeriodRangeStart
P90D
CY2017 clsd Short Term Investments Maturity Period Range End
ShortTermInvestmentsMaturityPeriodRangeEnd
P365D
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1132000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
262000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
247000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
168000
CY2017Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
3360000
CY2016Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1153000
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
920000
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
870000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
62000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
410000
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
113000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
101000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
88000
CY2017Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
18000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
72000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
58000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
52000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
203000
CY2016Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
13000
CY2015Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
28000
CY2017Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2016Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2015Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
234000
CY2016 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
287000
CY2015 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
115000
CY2016 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
283000
CY2015 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
101000
CY2016 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
17000
CY2015 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
7400
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3200000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3200000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1600000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
8000000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInNextTwelveMonths
476000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearTwo
234000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearThree
545000
CY2017Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPayment
9255000
CY2016Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
9614159
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47314000
CY2016 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
884000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27999000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14119000
CY2017Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
248000
CY2016Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
358000
CY2015Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
230000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
49000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
1000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
4000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
38000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
69000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
77000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
387000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32670000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25446000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15605000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0242
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0379
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0454
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0284
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0198
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0126
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0397
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0162
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0266
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1242
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3743
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3994
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.2513
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2017 clsd Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
14900000
CY2017 clsd Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Increase In Deferred Income Tax Valuation Allowance
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateIncreaseInDeferredIncomeTaxValuationAllowance
7200000
CY2016 clsd Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Increase In Deferred Income Tax Valuation Allowance
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateIncreaseInDeferredIncomeTaxValuationAllowance
9800000
CY2015 clsd Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Increase In Deferred Income Tax Valuation Allowance
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateIncreaseInDeferredIncomeTaxValuationAllowance
7000000
CY2017 clsd Deferred Tax Assets Operating Loss Carryforwards Expiration Year
DeferredTaxAssetsOperatingLossCarryforwardsExpirationYear
2037
CY2017 clsd Non Cancelable Operating Leases Expiration Month And Year
NonCancelableOperatingLeasesExpirationMonthAndYear
2017-03
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
431000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
444000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
458000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
472000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
487000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
373000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2665000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
214000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
81000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
150000
CY2017 clsd Revenue From Collaborative Agreements
RevenueFromCollaborativeAgreements
325000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
28424000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000
CY2017Q4 clsd Fair Value Assets Between Level1 Level2 And Level3 Transfers Amount
FairValueAssetsBetweenLevel1Level2AndLevel3TransfersAmount
0
CY2016Q4 clsd Fair Value Assets Between Level1 Level2 And Level3 Transfers Amount
FairValueAssetsBetweenLevel1Level2AndLevel3TransfersAmount
0
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38000000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
83991000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3105145
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2273371
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10886950
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
10261000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
13768000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
18348000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
16376000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-10373000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-13773000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-18336000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-16493000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
5862000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
5183000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
5311000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
9362000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-5449000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-5102000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-5645000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-9686000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.05
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45

Files In Submission

Name View Source Status
0001564590-18-006055-index-headers.html Edgar Link pending
0001564590-18-006055-index.html Edgar Link pending
0001564590-18-006055.txt Edgar Link pending
0001564590-18-006055-xbrl.zip Edgar Link pending
clsd-10k_20171231.htm Edgar Link pending
clsd-20171231.xml Edgar Link completed
clsd-20171231.xsd Edgar Link pending
clsd-20171231_cal.xml Edgar Link unprocessable
clsd-20171231_def.xml Edgar Link unprocessable
clsd-20171231_lab.xml Edgar Link unprocessable
clsd-20171231_pre.xml Edgar Link unprocessable
clsd-ex231_7.htm Edgar Link pending
clsd-ex311_10.htm Edgar Link pending
clsd-ex312_6.htm Edgar Link pending
clsd-ex321_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018031619545048915284.jpg Edgar Link pending
g2018031619545049115285.jpg Edgar Link pending
g2018031619545049815286.jpg Edgar Link pending
g2018031619545050015287.jpg Edgar Link pending
g2018031619545050615288.jpg Edgar Link pending
g2018031619545050815289.jpg Edgar Link pending
g2018031619545052515290.jpg Edgar Link pending
g2018031619545053115291.jpg Edgar Link pending
g2018031619545086215292.jpg Edgar Link pending
g2018031619550160615293.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending